XTL Biopharmaceuticals — Post-IPO Equity
XTL Biopharmaceuticals raised $2.8M in a Post-IPO Equity round. View investors, financials, and press on Fsome.
Round Details
- Funded Company
- XTL Biopharmaceuticals
- Round Type
- Post-IPO Equity
- Amount Raised
- $2.8M
- Announced
- March 7, 2017
Canonical: https://fsome.com/funding/xtl-biopharmaceuticals-post-ipo-equity-6516251 · For the full investor list, press references, and related rounds, please enable JavaScript.